PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026Cancer Discovery0 citations

Plasticity as Resistance: KRAS Inhibition Reveals WNT Adaptation in Metastatic Colorectal Cancer

View Full Paper
GEGeorge EngOYOmer H. Yilmaz

Key Points

  • The research aims to understand how KRASG12D inhibition affects cell states in metastatic colorectal cancer.
  • Inhibition of KRASG12D in colorectal cancer cells.
  • Real-time live cell imaging to observe cell state changes.
  • Transcriptional analysis to identify changes from EMP1+ to LGR5+ state.
  • KRAS inhibition leads to a shift from EMP1+ to LGR5+ stem cell–like state.
  • Identified cell state conversion as a mechanism of therapeutic resistance.
  • Potential for combinatorial targeting to exploit this resistance.

Abstract

Summary: Centonze and colleagues demonstrate that KRASG12D inhibition in metastatic colorectal cancer triggers rapid transcriptional reprogramming from a metastasis-associated EMP1+ state to a WNT-driven LGR5+ stem cell–like state, a plastic adaptation captured through real-time live cell imaging, revealing cell state conversion as a mechanism of therapeutic resistance that can be exploited through combinatorial targeting. See related article by Centonze et al., p. 320

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Eng et al. (2026) studied this question.

synapsesocial.com/papers/698827670fc35cd7a88462f1https://doi.org/10.1158/2159-8290.cd-25-2147
Ask AI
Helpful
Bookmark
Share
View Full Paper